elan: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Million (M) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Gross profit	2,004	1,397	684	-
Research and development	275	186	94	-
Marketing and selling	717	497	225	-
General and administrative	375	244	116	-
Interest expense, net of capitalized interest	140	88	40	-
Other expense, net	-23	-23	-12	-
Income tax (benefit) expense	-9	7	-7	-
Total other significant segment expenses	1,521	1,045	480	-
Other expenses (income)	439	274	137	-
Net income	44	78	67	346
Depreciation and amortization	506	330	161	498
Goodwill impairment	-	-	-	0
Stock-based compensation expense	52	35	15	40
Asset impairment and write-down charges	24	0	-	76
Gain on divestiture	0	-	-	640
Sold portion of royalty revenue	10	4	-	-
Proceeds from interest rate swap settlements	-	-	-	5
Interest on liability for sale of future revenue	20	7	-	-
Changes in operating assets and liabilities, net of acquisitions and divestitures	126	185	237	-93
Other non-cash operating activities, net	-58	-28	-10	-54
Net cash provided by operating activities	452	233	-4	364
Net purchases of property and equipment and software	214	122	65	100
Cash paid for acquisitions	-	-	-	5
Proceeds from divestitures	9	9	9	1,294
Proceeds from previous sale of shawnee and speke facilities (see note 4)	-	-	-	66
Purchases of intangible assets	-	-	-	8
Other investing activities, net	10	1	2	-1
Net cash (used for) provided by investing activities	-215	-114	-58	1,248
Proceeds from facility-Revolving Credit Facility	125	125	125	50
Repayments of facility-Revolving Credit Facility	125	125	125	250
Proceeds from facility-Securitization Facility	125	125	125	170
Repayments of facility-Securitization Facility	125	125	40	170
Proceeds from issuance of long-term debt	0	-	-	350
Repayments of long-term borrowings	562	374	13	1,587
Proceeds from sale of future revenue, net of transaction costs	290	290	-	-
Other financing activities, net	15	-20	-20	-23
Net cash used for financing activities	-257	-104	52	-1,460
Effect of exchange rate changes on cash and cash equivalents	57	56	29	-14
Net increase in cash and cash equivalents	37	71	19	138
Cash and cash equivalents at beginning of period	468	468	468	352
Cash and cash equivalents at end of period	505	539	487	490

Unit: Million (M) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

elan: the cashflow